Balázs has a physics degree from Imperial College London and earned a PhD in computational neuroscience from the University of Edinburgh. After graduating, he spent a few years as a biomedical software engineer at the Icahn Institute of Genetics in New York. He became involved with psychedelics science in 2016, when he started collaborating with the Global Drug Survey. He invented ‘self-blinding’, a novel methodology that enables self-experimenters to implement their own placebo control without clinical supervision. Using this methodology, Balázs designed and lead the self-blinding microdose study, the largest placebo-controlled study on psychedelics microdosing to-date. Balázs is currently a postdoctoral researcher at Imperial College’s Center for Psychedelic Research where he investigates the intersection of placebo effect and psychedelic medicine.

Share This